Catalyst Wire Dossier Catalyst Wire Dossier

Serelaxin

serelaxin · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Serelaxin, covering 2015-10-12 to 2019-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Vascular Effects of Serelaxin [Phase 2]

See pricing